APA
Yamout B. I., Dahdaleh M., Al Jumah M. A., Al-Shammri S., Al Sharoqi I., Al-Tahan A. R., Bohlega S., Deleu D., Inshasi J., Khalifa A. & Szólics M. (20100708). Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group. : The International journal of neuroscience.
Chicago
Yamout Bassem I, Dahdaleh Maurice, Al Jumah Mohammed Ali, Al-Shammri Suhail, Al Sharoqi Isa, Al-Tahan Abdel Rahman, Bohlega Saeed, Deleu Dirk, Inshasi Jihad, Khalifa Ahmad and Szólics Miklos. 20100708. Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group. : The International journal of neuroscience.
Harvard
Yamout B. I., Dahdaleh M., Al Jumah M. A., Al-Shammri S., Al Sharoqi I., Al-Tahan A. R., Bohlega S., Deleu D., Inshasi J., Khalifa A. and Szólics M. (20100708). Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group. : The International journal of neuroscience.
MLA
Yamout Bassem I, Dahdaleh Maurice, Al Jumah Mohammed Ali, Al-Shammri Suhail, Al Sharoqi Isa, Al-Tahan Abdel Rahman, Bohlega Saeed, Deleu Dirk, Inshasi Jihad, Khalifa Ahmad and Szólics Miklos. Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group. : The International journal of neuroscience. 20100708.